Indy Hematology Review Presentation Archive 2019 MULTIPLE MYELOMA: CHANGING & EMERGING TREATMENT PARADIGMS – Kenneth Anderson, MD STATE OF THE ART: 2019 EMERGING THERAPIES IN HEMATOLOGIC MALIGNANCIES – Ruemu E. Birhiray, MD NOT SO BENIGN HEMATOLOGY: COMPLEMENTOPATHIES AND APLASTIC ANEMIA – Robert Brodsky, MD INDOLENT LYMPHOMAS AND HODGKIN’S LYMPHOMA: ACHIEVING CURABILITY – Bruce Cheson, MD, FACP, FAAS, FASCO HEMATOPOIETIC STEM CELL TRANSPLANTATION: HOW I TREAT AND WHEN I TRANSPLANT IN 2019 – Richard Childs, MD, RADM, USPHS PRACTICAL CONSIDERATIONS IN THE TREATMENT MYELOPROLIFERATIVE NEOPLASMS: PROGNOSTIFICATION AND CURRENT TREATMENT – Angela Fleischman, MD, PhD ACUTE LYMPHOBLASTIC LEUKEMIA: EMERGING AND TARGETED THERAPIES – Hagop Kantarjian, MD BENIGN HEMATOLOGY: CYTOPENIAS, CLOTTING, AND BLEEDING – Craig Kessler, MD CHRONIC MYELOID LEUKEMIA: TARGETED THERAPY IN 2019 – Richard Larson, MD AGGRESSIVE B AND T CELL LYMPHOMAS: CHEMOTHERAPY, ANTIBODIES, IMMUNOTHERAPY – John Leonard, MD MYELODYSPLASTIC SYNDROME; HOW MUCH FURTHER DO WE HAVE TO TRAVEL? – Richard Stone, MD ACUTE MYELOID LEUKEMIAS: TREATMENT OPTIONS IN 2019 – Martin Tallman, MD GENOMIC BASED TREATMENT OF WALDENSTRÖM’S MACROGLOBULINEMIA – Steven Treon, MD, MA, PhD, FACP, FRCP CHALLENGING CASES PRESENTATION – Michael C. Wiemann, MD, FACP – Co-Chair CHRONIC LYMPHOCYTIC LEUKEMIA: HOW TO TREAT IN 2019 – Jennifer Woyach, MD
